Drag a card by its title · ⚙ to size, swap or remove

The company

Pelthos Therapeutics Inc.

PTHS · NYSE American

Health CarePharmaceuticalsNot moving yet

PTHS stood above a rising 150-day average in 16 of the last 52 weekly readings, and has been out of that trend for the last 8 weeks. It is 19.1% below that average now. Pharmaceuticals: 31% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 8
Industry in uptrend: 31% -7 in 4 wk
Insider buys, 12 months: $2.0M
Insider sales, 12 months: $647K
Officials’ trades on record: 0
Institutions holding: 23 (+6)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.

17 Apr – 16 Oct

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1

Sale orders, 12 months13

Buyers · sellers1 · 5

Who	Did	Shares	Traded
Matthew PaulsDirector	sold	786at $21.00	2 Oct 2026filed 6 Oct 2026
Ezra M. FriedbergDirector	sold	558at $20.72	2 Oct 2026filed 6 Oct 2026
Peter GreenleafDirector	sold	797at $21.17	2 Oct 2026filed 6 Oct 2026
Peter GreenleafDirector	sold	712at $26.00	2 Jul 2026filed 7 Jul 2026
Peter GreenleafDirector	sold	85at $27.27	2 Jul 2026filed 7 Jul 2026
Matthew PaulsDirector	sold	692at $26.00	2 Jul 2026filed 7 Jul 2026
Matthew PaulsDirector	sold	94at $27.36	2 Jul 2026filed 7 Jul 2026
Ezra M. FriedbergDirector	sold	534at $26.03	2 Jul 2026filed 7 Jul 2026
Ezra M. FriedbergDirector	sold	24at $27.33	2 Jul 2026filed 7 Jul 2026
Ezra M. FriedbergDirector	sold	224at $27.12	15 Jun 2026filed 17 Jun 2026
Ezra M. FriedbergDirector	sold	59at $27.94	15 Jun 2026filed 17 Jun 2026
Todd C. DavisDirector	bought	35,445at $27.80	11 Jun 2026filed 15 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders23+6 on the quarter

New · exited9 · 3

Reported value$37.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
AIGH Capital Management LLCnew · filed 7 Aug 2026	329,098$9.3M	+329,098
Murchinson Ltd.added · filed 14 Aug 2026	304,302$8.6M	+7,988+2.7%
Ikarian Capital, LLCunchanged · filed 14 Aug 2026	256,598$7.3M	00.0%
BOOTHBAY FUND MANAGEMENT, LLCadded · filed 14 Aug 2026	101,976$2.9M	+20,118+24.6%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	97,134$2.7M	+4,041+4.3%
CANTOR FITZGERALD, L. P.reduced · filed 14 Aug 2026	38,123$1.1M	-3,300−8.0%
J. Goldman & Co LPreduced · filed 14 Aug 2026	38,075$1.1M	-12,340−24.5%
DIADEMA PARTNERS LPunchanged · filed 14 Aug 2026	24,773$700K	00.0%
WEXFORD CAPITAL LPnew · filed 14 Aug 2026	22,364$632K	+22,364
Knott David M Jradded · filed 12 Aug 2026	22,073$624K	+1,000+4.7%